GW Pharma (GWPH) PT Raised to $164 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts GWPH Hot Sheet
Price: $218.96 --0%
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao raised the price target on GW Pharma (NASDAQ: GWPH) to $164.00 (from $161.00) while maintaining a Buy rating.
You May Also Be Interested In
- Hypera SA (HYPE3:BZ) (HYPMY) PT Lowered to R$28.50 at UBS
- Arista Networks (ANET) PT Raised to $240 at Truist Securities
- RXO, Inc. (RXO) PT Raised to $30.25 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
